Medtronic received information via literature review regarding transcatheter pulmonary valve replacement contributing to ongoing improvement in cardiac function.All data were collected from a single center between march 1, 2010 and march 1, 2011.The study population included 22 patients (mean age 17 years, gender and weight data not provided), all of which were implanted with medtronic melody transcatheter valves (serial numbers not provided).Among all patients adverse events included: pulmonary regurgitation (6 mild, 9 moderate), stenosis, and valve obstruction.Additionally, 2 of the 22 patients underwent a valve-in-vale implant procedure to address 1 valve frame fracture and 1 obstruction of the original valve.No additional adverse patient effects were reported.
|